CERo Therapeutics Holdings, Inc. (CERO)

SG&A Expenses

$7.82M

TTM · Period ending: · USD

CERO logo

CERO SG&A Expenses

Latest reported$7.82M
CERO SG&A Expenses ($2.48M → $7.82M)
High-resolution chart · PNG

CERO sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

CERo Therapeutics Holdings, Inc. SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
8,081,205
8,985,000
2,892,935
2,841,391
2,479,447
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.